Aprameya Engineering (NSE:APRAMEYA) PE Ratio without NRI: 57.44 (As of Jul. 02, 2026) — 68% Above Median


NSE:APRAMEYA Aprameya Engineering Ltd NSE:APRAMEYA
41 GF Score
Price ₹153.95
! 6 Warning Signs
View Full Analysis

What is Aprameya Engineering PE Ratio without NRI?

Aprameya Engineering NSE:APRAMEYA -0.68% 41 PE Ratio without NRI is 57.44 as of Jul. 02, 2026, which is 68% above its 10-year median of 34.29. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 41/100. The stock has 6 warning signs investors should review. Among 446 Medical Devices & Instruments companies, Aprameya Engineering ranks worse than 83.41% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-07-02), Aprameya Engineering's share price is ₹153.95. Aprameya Engineering's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.68. Therefore, Aprameya Engineering's PE Ratio without NRI for today is 57.44.

During the past 7 years, Aprameya Engineering's highest PE Ratio without NRI was 88.25. The lowest was 10.25. And the median was 34.29.

Aprameya Engineering's EPS without NRI for the six months ended in Mar. 2026 was ₹2.68. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.68.

As of today (2026-07-02), Aprameya Engineering's share price is ₹153.95. Aprameya Engineering's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.68. Therefore, Aprameya Engineering's PE Ratio (TTM) for today is 57.44.

During the past years, Aprameya Engineering's highest PE Ratio (TTM) was 88.25. The lowest was 10.25. And the median was 34.29.

Aprameya Engineering's EPS (Diluted) for the six months ended in Mar. 2026 was ₹2.68. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.68.

Aprameya Engineering's EPS (Basic) for the six months ended in Mar. 2026 was ₹2.68. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.68.


Aprameya Engineering  (NSE:APRAMEYA) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Aprameya Engineering PE Ratio without NRI Related Terms


Aprameya Engineering PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Aprameya Engineering's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprameya Engineering PE Ratio without NRI Chart

Aprameya Engineering Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PE Ratio without NRI
Get a 7-Day Free Trial N/A N/A N/A 11.05 75.99

Aprameya Engineering Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PE Ratio without NRI Get a 7-Day Free Trial N/A N/A N/A 11.05 75.99

NSE:APRAMEYA vs ISRG, BDX, MDLN: PE Ratio without NRI Comparison

For the Medical Instruments & Supplies subindustry, Aprameya Engineering's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aprameya Engineering PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aprameya Engineering's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Aprameya Engineering's PE Ratio without NRI falls into.


NSE:APRAMEYA
41GF Score
Aprameya Engineering Ltd NSE:APRAMEYA
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aprameya Engineering PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Aprameya Engineering's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=153.95/2.680
=57.44

Aprameya Engineering's Share Price of today is ₹153.95.
For company reported annually, GuruFocus uses latest annual data as the TTM data. Aprameya Engineering's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.68.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 57.44 mean?
Aprameya Engineering (NSE:APRAMEYA) has a PE Ratio without NRI of 57.44 as of Jul. 02, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Aprameya Engineering and its competitors. This is 68% above median its historical median of 34.29. Over the past decade, Aprameya Engineering's PE Ratio without NRI has ranged from 10.25 to 88.25. According to the industry distribution chart, Aprameya Engineering ranks #372 out of 446 companies in the Medical Devices & Instruments industry, placing it in the top 83.4%.
Is Aprameya Engineering's PE Ratio without NRI too high?
Aprameya Engineering's current PE Ratio without NRI of 57.44 is 68% above median its 10-year median of 34.29. Over the past 10 years, this metric has ranged from a low of 10.25 to a high of 88.25. The Medical Devices & Instruments industry median PE Ratio without NRI is 23.62. Aprameya Engineering's value of 57.44 is 143.2% above this industry median. Based on the distribution chart, Aprameya Engineering ranks #372 out of 446 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Aprameya Engineering has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's PE Ratio without NRI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aprameya Engineering ranks #372 out of 446 companies for PE Ratio without NRI. This places Aprameya Engineering in the lower half of its industry. The industry median PE Ratio without NRI is 23.62. Aprameya Engineering's value of 57.44 is 143.2% above this benchmark. Historically, Aprameya Engineering's own PE Ratio without NRI has ranged from 10.25 to 88.25 over the past decade. While the company's 10-year median is 34.29 vs. the industry median of 23.62, Aprameya Engineering has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Medical Devices & Instruments company?
The median PE Ratio without NRI among Medical Devices & Instruments companies is 23.62, based on 446 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aprameya Engineering's current PE Ratio without NRI of 57.44 is 143.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Aprameya Engineering and its competitors. For the Medical Devices & Instruments industry, the median PE Ratio without NRI is 23.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aprameya Engineering's current PE Ratio without NRI is 57.44, which is 68% above median its own 10-year median of 34.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current PE Ratio without NRI of 57.44. The current PE Ratio without NRI is 57.44, which is 68% above median its 10-year median of 34.29 and 143.2% above the Medical Devices & Instruments industry median of 23.62. Aprameya Engineering's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current PE Ratio without NRI is 57.44 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprameya Engineering Business Description

Address 908, 9th Floor, Venus Atlantis Corporate Park, Anandnagar, Prahladnagar, Ahmedabad, GJ, IND, 380015
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
41GF Score

Get the complete analysis for NSE:APRAMEYA

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹153.95
Price